Header Logo

David Moore

Concepts (558)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
106
2022
4946
6.280
Why?
Medication Adherence
15
2022
137
4.190
Why?
Male
128
2022
6489
3.260
Why?
Middle Aged
85
2022
3425
2.920
Why?
Humans
161
2022
14077
2.880
Why?
Neurocognitive Disorders
11
2021
13
2.880
Why?
Anti-Retroviral Agents
16
2021
542
2.850
Why?
AIDS Dementia Complex
14
2021
29
2.790
Why?
Female
122
2021
8751
2.600
Why?
Adult
100
2021
5664
2.510
Why?
Antiretroviral Therapy, Highly Active
29
2021
468
2.490
Why?
Aged
46
2022
1650
2.360
Why?
Anti-HIV Agents
30
2021
1275
2.340
Why?
Cognition Disorders
14
2018
35
2.220
Why?
Text Messaging
5
2020
25
2.140
Why?
Frailty
6
2021
15
2.080
Why?
Cognitive Dysfunction
4
2021
12
1.840
Why?
Brain
10
2021
53
1.830
Why?
Neuropsychological Tests
28
2022
55
1.810
Why?
Bipolar Disorder
5
2019
5
1.790
Why?
Alzheimer Disease
5
2021
30
1.720
Why?
Aging
12
2021
109
1.720
Why?
Depression
6
2022
117
1.720
Why?
Hospitalization
13
2021
392
1.690
Why?
Pneumonia
3
2021
127
1.550
Why?
Inflammation
3
2021
103
1.480
Why?
HIV-1
12
2021
1239
1.360
Why?
Mycobacterium tuberculosis
6
2022
326
1.310
Why?
Risk Factors
33
2021
1431
1.250
Why?
Infant
34
2021
2145
1.190
Why?
Reminder Systems
2
2019
8
1.150
Why?
Pneumococcal Vaccines
10
2019
252
1.150
Why?
AIDS-Related Opportunistic Infections
4
2021
194
1.150
Why?
Cross-Sectional Studies
22
2022
1377
1.120
Why?
Child, Preschool
28
2021
1675
1.110
Why?
Pre-Exposure Prophylaxis
5
2022
171
1.100
Why?
Tuberculosis, Multidrug-Resistant
5
2022
210
1.100
Why?
Executive Function
6
2020
23
1.060
Why?
Methamphetamine
7
2020
7
1.060
Why?
Pneumococcal Infections
8
2019
287
1.040
Why?
Age Factors
6
2020
364
1.030
Why?
Telemedicine
3
2020
25
0.990
Why?
Quality of Life
6
2021
170
0.930
Why?
HIV Seropositivity
8
2020
263
0.910
Why?
Neurodegenerative Diseases
3
2018
19
0.910
Why?
Cohort Studies
24
2021
939
0.900
Why?
Logistic Models
16
2021
252
0.890
Why?
Coinfection
7
2021
268
0.890
Why?
Comorbidity
13
2021
184
0.890
Why?
Viral Load
15
2020
808
0.880
Why?
Adolescent
36
2021
2858
0.850
Why?
Aged, 80 and over
10
2022
449
0.850
Why?
Amphetamine-Related Disorders
4
2020
5
0.830
Why?
HIV Seronegativity
3
2020
52
0.820
Why?
Case-Control Studies
16
2022
464
0.800
Why?
Longitudinal Studies
9
2021
409
0.750
Why?
Streptococcus pneumoniae
6
2017
320
0.730
Why?
CD4 Lymphocyte Count
21
2021
654
0.720
Why?
Health Services Accessibility
3
2019
265
0.690
Why?
Prevalence
16
2020
1149
0.690
Why?
Disease Management
2
2019
73
0.690
Why?
Primary Health Care
5
2018
228
0.680
Why?
Substance-Related Disorders
8
2019
49
0.670
Why?
Population Groups
1
2019
9
0.670
Why?
Young Adult
23
2021
2357
0.670
Why?
Sexual Behavior
6
2019
313
0.670
Why?
Psychotherapy
1
2019
2
0.670
Why?
Needs Assessment
1
2019
29
0.660
Why?
Organophosphates
2
2019
8
0.660
Why?
Central Nervous System Stimulants
3
2016
4
0.660
Why?
Child
22
2021
2180
0.660
Why?
Patient Education as Topic
1
2019
48
0.650
Why?
Follow-Up Studies
16
2021
367
0.650
Why?
Blood-Brain Barrier
1
2019
23
0.640
Why?
Rural Health Services
1
2019
48
0.640
Why?
Adenine
2
2019
88
0.630
Why?
Hypertension
3
2019
397
0.620
Why?
Homosexuality, Male
7
2022
48
0.600
Why?
Alcoholism
1
2017
17
0.580
Why?
Cystatin C
1
2017
9
0.570
Why?
South Africa
26
2021
7312
0.560
Why?
Tuberculosis, Pulmonary
4
2017
320
0.560
Why?
Developing Countries
6
2021
385
0.550
Why?
Treatment Outcome
12
2021
867
0.540
Why?
Picornaviridae Infections
3
2021
18
0.530
Why?
Immunoconjugates
1
2015
1
0.530
Why?
Antipsychotic Agents
2
2012
10
0.530
Why?
Retrospective Studies
16
2021
767
0.520
Why?
HIV
4
2018
380
0.520
Why?
Pharmaceutical Preparations
1
2015
44
0.510
Why?
Mental Recall
1
2015
3
0.510
Why?
Pain
1
2015
40
0.500
Why?
Antitubercular Agents
6
2022
299
0.500
Why?
Tuberculosis
5
2014
530
0.500
Why?
Craniosynostoses
1
2015
1
0.490
Why?
Blood Loss, Surgical
1
2015
5
0.490
Why?
Blood Transfusion
1
2015
11
0.490
Why?
Antibodies, Monoclonal
1
2015
137
0.480
Why?
Vaccination
5
2021
347
0.480
Why?
Pneumonia, Viral
3
2021
102
0.470
Why?
Child Development
1
2015
89
0.460
Why?
Infant, Newborn
11
2021
1410
0.450
Why?
Activities of Daily Living
7
2017
39
0.450
Why?
Incidence
14
2021
655
0.430
Why?
Nasopharynx
4
2021
148
0.430
Why?
Respiratory System
1
2012
9
0.420
Why?
Health Status Indicators
2
2020
17
0.410
Why?
Child Health
3
2021
76
0.410
Why?
Cognition
5
2022
75
0.400
Why?
Rhinovirus
3
2021
23
0.400
Why?
Pancreatitis, Chronic
2
2021
4
0.400
Why?
Virus Diseases
1
2012
55
0.400
Why?
Patient Acuity
2
2021
18
0.390
Why?
Exercise
4
2019
203
0.380
Why?
Bayes Theorem
2
2021
77
0.380
Why?
Amyloid beta-Peptides
4
2019
22
0.370
Why?
Transgender Persons
3
2019
21
0.370
Why?
California
6
2017
9
0.360
Why?
Surveys and Questionnaires
9
2021
532
0.360
Why?
Mental Status and Dementia Tests
2
2021
5
0.350
Why?
Depressive Disorder
2
2020
10
0.340
Why?
Feasibility Studies
4
2019
95
0.340
Why?
Community-Acquired Infections
1
2010
93
0.340
Why?
Pneumonia, Pneumococcal
1
2010
93
0.340
Why?
Genotype
5
2019
430
0.340
Why?
Risk-Taking
4
2019
119
0.330
Why?
Prospective Studies
13
2021
1131
0.330
Why?
Uveitis
2
2019
5
0.330
Why?
Psychiatric Status Rating Scales
4
2020
25
0.330
Why?
Gastroesophageal Reflux
2
2021
3
0.330
Why?
Metabolic Syndrome
2
2020
63
0.330
Why?
Secondary Prevention
2
2022
20
0.320
Why?
Focus Groups
3
2020
180
0.320
Why?
Clinical Trials as Topic
2
2021
112
0.310
Why?
Proteins
2
2019
20
0.310
Why?
Uganda
12
2016
194
0.310
Why?
Acquired Immunodeficiency Syndrome
5
2014
186
0.310
Why?
Sexual and Gender Minorities
2
2019
28
0.310
Why?
Primary Prevention
2
2019
27
0.300
Why?
Infant Mortality
2
2010
92
0.300
Why?
Unsafe Sex
2
2019
45
0.290
Why?
Vaccines, Conjugate
3
2019
161
0.290
Why?
Biomarkers
5
2022
322
0.280
Why?
Sustained Virologic Response
2
2017
22
0.280
Why?
Mass Screening
4
2018
242
0.280
Why?
RNA, Viral
6
2020
303
0.270
Why?
Mobile Applications
2
2016
12
0.260
Why?
Sexual Partners
5
2019
211
0.260
Why?
Cardiovascular Agents
2
2016
11
0.260
Why?
Pneumonia, Bacterial
2
2016
54
0.260
Why?
Coronary Disease
2
2016
17
0.260
Why?
Social Support
2
2018
76
0.260
Why?
Patient Acceptance of Health Care
2
2019
235
0.260
Why?
Veterans
2
2016
2
0.250
Why?
Multivariate Analysis
6
2019
171
0.250
Why?
Memory
3
2021
3
0.240
Why?
Graft Survival
2
2021
40
0.240
Why?
Cause of Death
2
2017
206
0.240
Why?
Socioeconomic Factors
7
2015
405
0.240
Why?
Alcohol Drinking
2
2017
53
0.230
Why?
Depressive Disorder, Major
2
2022
20
0.220
Why?
African Americans
2
2020
47
0.220
Why?
Predictive Value of Tests
4
2018
183
0.220
Why?
Visual Acuity
2
2021
4
0.210
Why?
Severity of Illness Index
5
2019
243
0.210
Why?
Diagnosis, Differential
2
2021
63
0.210
Why?
Neopterin
1
2022
4
0.200
Why?
Risk Assessment
4
2016
217
0.200
Why?
Syphilis
1
2022
14
0.200
Why?
Recurrence
1
2022
27
0.200
Why?
Cerebral Amyloid Angiopathy
2
2019
2
0.200
Why?
Frail Elderly
1
2021
15
0.200
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
3
2012
19
0.200
Why?
Serogroup
3
2017
134
0.200
Why?
Trypsin
1
2021
2
0.200
Why?
Pancreatectomy
1
2021
2
0.200
Why?
Graft Rejection
1
2021
14
0.200
Why?
Tenofovir
2
2021
158
0.200
Why?
Anxiety Disorders
1
2021
13
0.190
Why?
Qualitative Research
2
2020
294
0.190
Why?
Kidney Transplantation
1
2021
42
0.190
Why?
Coronavirus
1
2021
14
0.190
Why?
Cerebral Cortex
2
2015
9
0.190
Why?
Uveitis, Posterior
1
2021
1
0.190
Why?
Drug Resistance, Multiple, Bacterial
2
2018
37
0.190
Why?
Endpoint Determination
1
2021
8
0.190
Why?
Air Pollution
1
2021
2
0.190
Why?
Anxiety
1
2021
39
0.190
Why?
Animals
2
2015
1063
0.190
Why?
Biomedical Technology
1
2021
10
0.190
Why?
Sexually Transmitted Diseases
1
2022
101
0.190
Why?
Life Expectancy
2
2019
31
0.190
Why?
Delivery of Health Care, Integrated
2
2018
33
0.190
Why?
Air Pollution, Indoor
1
2021
13
0.180
Why?
Genome, Bacterial
2
2018
28
0.180
Why?
Reoperation
1
2020
8
0.180
Why?
Diagnostic Self Evaluation
1
2020
3
0.180
Why?
Hand Strength
1
2020
7
0.180
Why?
Impulsive Behavior
1
2020
2
0.180
Why?
Apathy
1
2020
2
0.180
Why?
Healthy Aging
1
2020
6
0.180
Why?
Motor Skills
1
2020
6
0.180
Why?
Minority Groups
1
2020
4
0.180
Why?
Sentinel Surveillance
2
2019
110
0.180
Why?
C-Reactive Protein
1
2021
96
0.180
Why?
Age Distribution
1
2020
106
0.180
Why?
Diabetes Mellitus
2
2021
137
0.180
Why?
Genetic Variation
3
2019
169
0.180
Why?
Coronavirus Infections
1
2021
70
0.170
Why?
Diagnosis, Computer-Assisted
1
2020
4
0.170
Why?
Cell Phone
1
2020
34
0.170
Why?
Uveitis, Anterior
1
2019
1
0.170
Why?
Mutation
5
2021
299
0.170
Why?
Arthritis, Rheumatoid
2
2013
158
0.170
Why?
Plaque, Amyloid
1
2019
1
0.170
Why?
Diagnostic Techniques, Ophthalmological
1
2019
3
0.170
Why?
Rural Health
3
2016
118
0.170
Why?
Radiography, Thoracic
1
2020
19
0.170
Why?
Aqueous Humor
1
2019
5
0.170
Why?
Liver Transplantation
1
2020
53
0.170
Why?
Photometry
1
2019
1
0.170
Why?
Tomography, Optical Coherence
1
2019
3
0.170
Why?
Anterior Chamber
1
2019
4
0.170
Why?
Congresses as Topic
1
2019
20
0.170
Why?
Viremia
1
2020
66
0.170
Why?
Islands
1
2019
2
0.170
Why?
Lakes
1
2019
3
0.170
Why?
Peru
1
2019
8
0.170
Why?
Diabetes Mellitus, Type 2
1
2021
132
0.170
Why?
Menopause
1
2019
24
0.170
Why?
Rubella Syndrome, Congenital
1
2019
5
0.170
Why?
World Health Organization
1
2020
134
0.170
Why?
Altitude
1
2019
9
0.170
Why?
Caregivers
2
2021
66
0.170
Why?
Macular Edema
1
2019
1
0.170
Why?
Life Style
2
2018
80
0.160
Why?
Cerebrospinal Fluid
2
2017
5
0.160
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
17
0.160
Why?
Neurofibrillary Tangles
1
2019
1
0.160
Why?
tau Proteins
1
2019
7
0.160
Why?
Atrophy
1
2019
6
0.160
Why?
Guidelines as Topic
1
2019
40
0.160
Why?
Glucocorticoids
1
2019
20
0.160
Why?
Neurons
1
2019
23
0.160
Why?
Research
1
2019
65
0.160
Why?
Psychology
1
2018
4
0.160
Why?
Inflammation Mediators
1
2019
22
0.160
Why?
Endemic Diseases
1
2018
15
0.160
Why?
Bacterial Infections
1
2019
53
0.160
Why?
Autopsy
2
2019
131
0.160
Why?
Carrier State
1
2019
89
0.160
Why?
Population Surveillance
2
2021
325
0.160
Why?
Europe
5
2017
53
0.160
Why?
Polymerase Chain Reaction
2
2016
260
0.160
Why?
Personal Satisfaction
1
2018
16
0.160
Why?
Apolipoprotein E4
2
2021
4
0.150
Why?
Bacteremia
2
2017
79
0.150
Why?
Time Factors
6
2018
503
0.150
Why?
Quality of Health Care
1
2018
58
0.150
Why?
Health Services Research
1
2018
57
0.150
Why?
Ambulatory Care
1
2018
54
0.150
Why?
Extensively Drug-Resistant Tuberculosis
1
2018
20
0.150
Why?
Antigens, Differentiation, Myelomonocytic
1
2017
2
0.150
Why?
Genetic Predisposition to Disease
2
2015
168
0.140
Why?
Receptors, Cell Surface
1
2017
6
0.140
Why?
Blood Coagulation Disorders
1
2017
6
0.140
Why?
Immunocompromised Host
1
2017
33
0.140
Why?
Chagas Disease
1
2017
1
0.140
Why?
Health Risk Behaviors
1
2017
7
0.140
Why?
Antigens, CD
1
2017
23
0.140
Why?
Emigrants and Immigrants
1
2017
11
0.140
Why?
Vascular Remodeling
1
2017
1
0.140
Why?
Antibodies, Viral
1
2019
266
0.140
Why?
Australia
3
2021
46
0.140
Why?
Proportional Hazards Models
4
2021
163
0.140
Why?
Benzoxazines
2
2015
119
0.140
Why?
Ecological Momentary Assessment
1
2016
1
0.140
Why?
Medical Informatics Applications
1
2016
1
0.140
Why?
Health Education
1
2017
35
0.140
Why?
Alleles
2
2016
134
0.140
Why?
Terminally Ill
1
2017
21
0.140
Why?
Immunogenicity, Vaccine
1
2017
91
0.140
Why?
United States
3
2021
129
0.140
Why?
Sex Workers
1
2018
114
0.140
Why?
Gastrostomy
1
2016
1
0.140
Why?
Fundoplication
1
2016
1
0.140
Why?
DNA Repeat Expansion
1
2016
1
0.140
Why?
Attitude to Health
1
2016
56
0.140
Why?
Postoperative Complications
1
2016
32
0.140
Why?
Biomedical Research
1
2017
48
0.140
Why?
Survival Analysis
3
2012
149
0.140
Why?
Vascular Stiffness
1
2017
41
0.130
Why?
Awareness
2
2015
18
0.130
Why?
Multigene Family
1
2016
6
0.130
Why?
Forecasting
1
2016
20
0.130
Why?
Virus Replication
1
2017
87
0.130
Why?
South Australia
3
2021
3
0.130
Why?
Disease Progression
3
2019
154
0.130
Why?
Mitochondria
1
2016
12
0.130
Why?
Genes, Bacterial
1
2016
23
0.130
Why?
Recombination, Genetic
1
2016
27
0.130
Why?
Drug Industry
1
2015
4
0.130
Why?
Mental Disorders
2
2013
40
0.130
Why?
Ataxia
1
2015
4
0.130
Why?
Bisexuality
1
2015
2
0.130
Why?
HIV Protease Inhibitors
2
2014
92
0.130
Why?
Chemokine CCL2
1
2015
10
0.130
Why?
Odds Ratio
5
2017
132
0.130
Why?
Immunohistochemistry
4
2019
26
0.130
Why?
Schizophrenic Psychology
1
2015
2
0.130
Why?
Schizophrenia
1
2015
4
0.130
Why?
Cardiology
1
2015
1
0.120
Why?
Psychomotor Performance
1
2015
12
0.120
Why?
Microtubule-Associated Proteins
1
2015
2
0.120
Why?
Synaptophysin
1
2015
3
0.120
Why?
Contact Tracing
1
2015
47
0.120
Why?
Hematologic Agents
1
2015
2
0.120
Why?
Postoperative Hemorrhage
1
2015
2
0.120
Why?
Perioperative Care
1
2015
8
0.120
Why?
Societies, Medical
1
2015
23
0.120
Why?
Risk Reduction Behavior
1
2015
39
0.120
Why?
Polymorphism, Single Nucleotide
1
2016
190
0.120
Why?
Meningitis, Bacterial
1
2015
32
0.120
Why?
Practice Patterns, Physicians'
1
2015
42
0.120
Why?
Cerebral Small Vessel Diseases
1
2014
1
0.120
Why?
Calcitriol
1
2014
6
0.120
Why?
Dermatologic Agents
1
2014
6
0.120
Why?
Zinc Sulfate
1
2014
6
0.120
Why?
Pregnancy Complications, Infectious
1
2019
507
0.120
Why?
Spatio-Temporal Analysis
1
2014
14
0.120
Why?
Tuberculin Test
1
2014
49
0.110
Why?
Smoking
2
2015
99
0.110
Why?
CD4-Positive T-Lymphocytes
2
2014
145
0.110
Why?
Mitochondrial Proteins
1
2013
1
0.110
Why?
Encephalitis
1
2013
2
0.110
Why?
Research Design
3
2021
123
0.110
Why?
Sequence Analysis, DNA
3
2019
180
0.110
Why?
Phylogeny
3
2019
231
0.110
Why?
Interview, Psychological
1
2012
6
0.110
Why?
Randomized Controlled Trials as Topic
2
2010
237
0.110
Why?
Hospitals, Pediatric
1
2012
5
0.100
Why?
Hippocampus
2
2017
2
0.100
Why?
Disease Models, Animal
1
2012
45
0.100
Why?
Memory Disorders
1
2012
1
0.100
Why?
Rural Population
3
2016
624
0.100
Why?
Dopamine Uptake Inhibitors
1
2012
1
0.100
Why?
Diagnosis, Dual (Psychiatry)
1
2012
1
0.100
Why?
Orthomyxoviridae
1
2012
33
0.100
Why?
Unemployment
1
2012
10
0.100
Why?
Adenoviridae
1
2012
39
0.100
Why?
British Columbia
3
2017
4
0.100
Why?
Sleep Initiation and Maintenance Disorders
1
2012
7
0.100
Why?
Mice
1
2012
134
0.100
Why?
Chemoprevention
1
2012
33
0.100
Why?
Attention
1
2011
5
0.100
Why?
Lipopolysaccharide Receptors
1
2011
10
0.100
Why?
Learning
1
2011
12
0.100
Why?
Anti-Infective Agents
2
2010
56
0.100
Why?
Kaplan-Meier Estimate
2
2021
103
0.090
Why?
Latin America
2
2017
10
0.090
Why?
Reverse Transcriptase Inhibitors
2
2008
113
0.090
Why?
Liver Diseases
2
2021
18
0.090
Why?
Linear Models
1
2010
82
0.090
Why?
Hospitals
2
2021
102
0.090
Why?
Influenza, Human
1
2014
360
0.090
Why?
Malaria
1
2012
207
0.080
Why?
Reproducibility of Results
3
2019
210
0.080
Why?
Educational Status
2
2013
68
0.080
Why?
Hematologic Diseases
1
2009
4
0.080
Why?
Sex Factors
3
2018
224
0.080
Why?
Family Characteristics
3
2016
133
0.080
Why?
Breast Feeding
1
2010
119
0.080
Why?
Zidovudine
1
2009
59
0.080
Why?
Smartphone
2
2020
4
0.080
Why?
Reproduction
1
2009
25
0.080
Why?
HIV Antibodies
1
2011
243
0.080
Why?
Intestine, Small
1
2008
4
0.080
Why?
Intestinal Mucosa
1
2008
9
0.080
Why?
Stavudine
1
2009
78
0.080
Why?
Liver
1
2008
74
0.080
Why?
Women
2
2009
12
0.080
Why?
Child, Orphaned
1
2008
16
0.080
Why?
Seasons
2
2021
149
0.070
Why?
Lipids
1
2008
81
0.070
Why?
Diet
2
2021
108
0.070
Why?
Safe Sex
2
2018
67
0.070
Why?
Pregnancy
3
2021
1815
0.070
Why?
Registries
2
2020
89
0.070
Why?
DNA, Bacterial
2
2018
53
0.070
Why?
Regression Analysis
2
2019
131
0.070
Why?
Putamen
1
2006
1
0.070
Why?
Microscopy, Confocal
1
2006
3
0.070
Why?
Plasma
2
2017
39
0.070
Why?
Psychometrics
1
2006
20
0.070
Why?
Health Status
2
2019
111
0.070
Why?
Infectious Disease Transmission, Vertical
1
2010
467
0.070
Why?
ROC Curve
2
2016
47
0.060
Why?
Self Report
2
2019
111
0.060
Why?
Cholesterol, HDL
2
2020
32
0.060
Why?
Triglycerides
2
2020
40
0.060
Why?
Risk
2
2020
87
0.060
Why?
Amyloidosis
1
2005
3
0.060
Why?
Canada
2
2015
11
0.060
Why?
Brain Diseases
1
2005
24
0.060
Why?
Caribbean Region
1
2003
11
0.060
Why?
Water Supply
1
2003
10
0.060
Why?
Infant Nutritional Physiological Phenomena
1
2003
17
0.060
Why?
Fluid Therapy
1
2003
24
0.060
Why?
United Kingdom
2
2013
32
0.060
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2003
28
0.060
Why?
Cost-Benefit Analysis
2
2017
235
0.050
Why?
Memory, Short-Term
2
2013
7
0.050
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2013
5
0.050
Why?
Hepatitis C
2
2014
37
0.050
Why?
Alkynes
2
2015
113
0.050
Why?
Cyclopropanes
2
2015
119
0.050
Why?
Drug Resistance, Viral
2
2014
268
0.050
Why?
Fatigue
1
2022
20
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2021
10
0.050
Why?
Transplantation, Autologous
1
2021
1
0.050
Why?
Islets of Langerhans Transplantation
1
2021
2
0.050
Why?
Prognosis
2
2016
197
0.050
Why?
Pain Measurement
2
2012
15
0.050
Why?
Respiratory Sounds
1
2021
10
0.050
Why?
Health Status Disparities
1
2021
34
0.050
Why?
Emtricitabine
1
2021
74
0.050
Why?
Multimorbidity
1
2021
42
0.050
Why?
Proton Pump Inhibitors
1
2021
2
0.050
Why?
Asia
1
2021
70
0.050
Why?
Zambia
1
2021
112
0.050
Why?
Ophthalmologists
1
2021
1
0.050
Why?
Patients
1
2021
3
0.050
Why?
Biomass
1
2021
2
0.050
Why?
Magnetic Resonance Imaging
1
2021
37
0.050
Why?
Cooking
1
2021
7
0.050
Why?
Delphi Technique
1
2021
28
0.050
Why?
Consensus
1
2021
59
0.050
Why?
New Zealand
1
2020
8
0.050
Why?
Waiting Lists
1
2020
8
0.050
Why?
Tissue Donors
1
2020
17
0.050
Why?
Harm Reduction
1
2020
7
0.040
Why?
Sickness Impact Profile
1
2020
2
0.040
Why?
Africa
1
2021
360
0.040
Why?
Protein Processing, Post-Translational
1
2019
10
0.040
Why?
Substance Abuse, Intravenous
2
2012
11
0.040
Why?
Employment
2
2013
27
0.040
Why?
5' Untranslated Regions
1
2019
7
0.040
Why?
Cell Count
1
2019
10
0.040
Why?
Motor Activity
2
2013
46
0.040
Why?
Molecular Epidemiology
1
2019
44
0.040
Why?
Health Personnel
1
2021
229
0.040
Why?
Genotyping Techniques
1
2019
38
0.040
Why?
Rubella virus
1
2019
8
0.040
Why?
Medical Records
1
2019
22
0.040
Why?
Drug Therapy, Combination
1
2019
271
0.040
Why?
Directive Counseling
1
2019
15
0.040
Why?
Health Surveys
1
2019
59
0.040
Why?
Chronic Disease
1
2019
100
0.040
Why?
Darunavir
1
2018
12
0.040
Why?
Mexico
1
2018
3
0.040
Why?
Renal Insufficiency, Chronic
1
2019
68
0.040
Why?
Models, Theoretical
1
2019
78
0.040
Why?
Drug Administration Schedule
2
2009
153
0.040
Why?
Non-Randomized Controlled Trials as Topic
1
2018
1
0.040
Why?
Respiratory Tract Infections
1
2021
251
0.040
Why?
Africa South of the Sahara
1
2019
328
0.040
Why?
Interrupted Time Series Analysis
1
2018
14
0.040
Why?
Ritonavir
1
2018
137
0.040
Why?
Geography
1
2018
60
0.040
Why?
Immunoenzyme Techniques
1
2017
21
0.040
Why?
Lung Diseases
1
2017
29
0.040
Why?
Immunity, Humoral
1
2017
42
0.040
Why?
Antiprotozoal Agents
1
2017
6
0.040
Why?
Angiopoietin-2
1
2017
1
0.040
Why?
Receptor, TIE-2
1
2017
1
0.040
Why?
Kidney Diseases
1
2017
38
0.040
Why?
Vascular Endothelial Growth Factor A
1
2017
14
0.040
Why?
Microbial Sensitivity Tests
1
2018
184
0.040
Why?
Immunization, Secondary
1
2017
62
0.040
Why?
Genome-Wide Association Study
1
2018
100
0.040
Why?
Heterosexuality
1
2016
30
0.030
Why?
Mosaicism
1
2016
1
0.030
Why?
C9orf72 Protein
1
2016
2
0.030
Why?
Scotland
1
2016
5
0.030
Why?
Artifacts
1
2016
3
0.030
Why?
Amyotrophic Lateral Sclerosis
1
2016
14
0.030
Why?
Interviews as Topic
1
2017
190
0.030
Why?
DNA Primers
1
2016
55
0.030
Why?
Antibodies, Bacterial
1
2017
149
0.030
Why?
DNA, Mitochondrial
1
2016
31
0.030
Why?
Base Sequence
1
2016
149
0.030
Why?
Selection, Genetic
1
2016
31
0.030
Why?
Evolution, Molecular
1
2016
60
0.030
Why?
Patient Compliance
2
2007
120
0.030
Why?
Knowledge
1
2015
2
0.030
Why?
Child, Hospitalized
1
2015
25
0.030
Why?
Immunoglobulin G
1
2017
220
0.030
Why?
Pakistan
1
2015
2
0.030
Why?
Genomics
1
2016
106
0.030
Why?
Smoking Cessation
1
2015
6
0.030
Why?
Statistics as Topic
1
2015
31
0.030
Why?
Health Care Surveys
1
2015
30
0.030
Why?
Sensitivity and Specificity
1
2016
380
0.030
Why?
Quality Assurance, Health Care
1
2015
43
0.030
Why?
Cytokines
1
2015
107
0.030
Why?
Guideline Adherence
1
2015
42
0.030
Why?
Drug Users
1
2014
3
0.030
Why?
North America
1
2014
11
0.030
Why?
Administration, Cutaneous
1
2014
31
0.030
Why?
Practice Guidelines as Topic
1
2015
123
0.030
Why?
Poisson Distribution
1
2014
18
0.030
Why?
Affect
1
2013
4
0.030
Why?
Foot Joints
1
2013
1
0.030
Why?
Hand Joints
1
2013
1
0.030
Why?
Phosphoproteins
1
2013
10
0.030
Why?
Social Stigma
1
2014
76
0.030
Why?
Task Performance and Analysis
1
2013
5
0.030
Why?
Acute Disease
1
2013
105
0.030
Why?
Carrier Proteins
1
2013
23
0.030
Why?
Radiography
1
2013
80
0.030
Why?
Statistics, Nonparametric
1
2013
38
0.030
Why?
Human Immunodeficiency Virus Proteins
1
2013
10
0.030
Why?
Community Health Services
1
2013
58
0.030
Why?
Stress, Psychological
1
2013
25
0.030
Why?
Military Personnel
1
2013
1
0.030
Why?
Communicable Disease Control
1
2014
101
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
77
0.030
Why?
Transients and Migrants
1
2013
39
0.030
Why?
Disease Outbreaks
1
2013
111
0.030
Why?
Early Diagnosis
1
2013
80
0.030
Why?
Verbal Learning
1
2012
3
0.030
Why?
Substance Abuse Detection
1
2012
2
0.030
Why?
DNA, Viral
1
2013
165
0.030
Why?
Withholding Treatment
1
2012
26
0.020
Why?
Quality-Adjusted Life Years
1
2011
26
0.020
Why?
Opioid-Related Disorders
1
2011
1
0.020
Why?
Disability Evaluation
1
2011
20
0.020
Why?
Diarrhea
1
2012
76
0.020
Why?
Lipopolysaccharides
1
2011
37
0.020
Why?
Mycobacterium
1
2011
16
0.020
Why?
Critical Illness
1
2010
42
0.020
Why?
Health Knowledge, Attitudes, Practice
1
2012
247
0.020
Why?
Hematologic Tests
1
2009
11
0.020
Why?
Transaminases
1
2008
5
0.020
Why?
Hyperplasia
1
2008
1
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2008
12
0.020
Why?
Home Care Services
1
2008
15
0.020
Why?
Mothers
1
2010
190
0.020
Why?
Cholesterol
1
2008
38
0.020
Why?
Survival Rate
1
2008
96
0.020
Why?
Child Mortality
1
2008
93
0.020
Why?
Nevirapine
1
2008
146
0.020
Why?
Cholesterol, LDL
1
2008
137
0.020
Why?
Paraffin Embedding
1
2005
2
0.020
Why?
Cardiovascular Diseases
1
2008
235
0.010
Why?
Neurologic Examination
1
2004
5
0.010
Why?
Chi-Square Distribution
1
2004
45
0.010
Why?
Analysis of Variance
1
2004
64
0.010
Why?
Moore's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (558)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_